Inventiva (IVEVF) Capital Expenditures (2019 - 2025)
Inventiva (IVEVF) posted Capital Expenditures of -$64521.7 for Q2 2025, up 76.5% on a QoQ basis from -$274606.3 in Q2 2024, and up 76.5% year-over-year from -$36555.4 in Q2 2024.
Analysis
Inventiva (IVEVF) Capital Expenditures (2019 - 2025) Analysis & Trends
Inventiva has reported Capital Expenditures for 5 years, with the latest figure at -$64521.7 in Q2 2025.
- On a quarterly basis, Capital Expenditures rose 76.5% year-over-year to -$64521.7 in Q2 2025; TTM through Jun 2025 was -$949979.4, a 10.9% increase from a year earlier, with the FY2025 full-year figure at -$287518.7, up 19.2% from the prior year.
- Capital Expenditures was -$64521.7 for Q2 2025 at Inventiva, up from -$274606.3 in the prior quarter.
- The five-year high for Capital Expenditures was -$49455.7 in Q1 2021, with the low at -$308858.1 in Q3 2022.
- Average Capital Expenditures over 4 years is -$188726.0, with a median of -$180747.4 recorded in 2021.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures plunged 67.08% in 2022, then jumped 76.5% in 2025.
- Over 4 years, Capital Expenditures stood at -$180747.4 in 2021, then slumped by 67.08% to -$301993.2 in 2022, then rose by 9.07% to -$274606.3 in 2024, then surged by 76.5% to -$64521.7 in 2025.
- The last three Capital Expenditures figures came in at -$64521.7 (Q2 2025), -$274606.3 (Q2 2024), and -$301993.2 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 533.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | 2.29 Mn |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 12.41 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 108.00 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -64,521.70 |
| Jun 30, 2024 | -274,606.33 |
| Dec 31, 2022 | -301,993.22 |
| Sep 22, 2022 | -308,858.12 |
| Dec 31, 2021 | -180,747.41 |
| Jun 30, 2021 | -140,899.76 |
| Mar 31, 2021 | -49,455.68 |
| Dec 31, 2019 | -161,605.60 |